Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


1 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
3 Antivir Ther
2 J Acquir Immune Defic Syndr
1 J Immunol
8 J Infect Dis
6 J Virol
2 Lancet
1 Lancet Glob Health
3 Lancet HIV
1 Lancet Infect Dis
2 MMWR Morb Mortal Wkly Rep
2 Pediatrics
1 PLoS Comput Biol
11 PLoS One
5 PLoS Pathog
1 Science
1 Vaccine
1 Virology


  1. DUQUENNE C, Gimenez S, Guigues A, Viala B, et al
    Reversing HIV latency via sphingosine-1-phosphate receptor 1 signaling.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001649.
    >> Share

  2. VAN HEUKELOM MLS, Marra E, de Vries HJC, van der Loeff MFS, et al
    Risk factors for anal HSIL in HIV-positive MSM: is targeted screening possible?
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001639.
    >> Share

  3. CHOW FC, Regan S, Zanni MV, Looby SE, et al
    Elevated ischemic stroke risk among women living with HIV infection.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001650.
    >> Share

  4. LAKE JE, Li X, Palella FJ Jr, Erlandson KM, et al
    Metabolic health across the body mass index spectrum in HIV-Infected and HIV-Uninfected Men.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001651.
    >> Share

  5. RODRIGUEZ-HART C, Nowak RG, Musci R, German D, et al
    Pathways from sexual stigma to incident HIV and sexually transmitted infections among Nigerian men who have sex with men.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001637.
    >> Share

  6. THORNTON AC, Jose S, Bhagani S, Chadwick D, et al
    Hepatitis B, hepatitis C and mortality among HIV-positive individuals.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001646.
    >> Share

  7. MIKULAK J, Oriolo F, Zaghi E, Di Vito C, et al
    Natural Killer cells in HIV-1 infection and therapy.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001645.
    >> Share

  8. KUNIHOLM MH, Liang H, Anastos K, Gustafson D, et al
    Association of a 3' Untranslated Region Polymorphism in PCSK9 with HIV Viral Load and CD4+ Levels in HIV/Hepatitis C Virus Co-Infected Women.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001648.
    >> Share

  9. BALASUBRAMANIAN R, Fowler MG, Dominguez K, Lockman S, et al
    Time to first positive HIV-1 DNA PCR may differ with antiretroviral regimen in infants infected with non-B subtype HIV-1.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001640.
    >> Share

  10. ANGELOVICH TA, Hearps AC, Oda MN, Borja MS, et al
    Dysfunctional HDL from HIV+ individuals promotes monocyte-derived foam cell formation in vitro.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001642.
    >> Share

  11. SCHEEPERS C, Chowdhury S, Wright WS, Campbell CT, et al
    Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001643.
    >> Share

  12. EWING AC, King CC, Wiener JB, Chasela CS, et al
    Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed, uninfected infants.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001641.
    >> Share

  13. BESSON C, Lancar R, Prevot S, Algarte-Genin M, et al
    Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern cART era.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001652.
    >> Share

  14. JAO J, Powis KM, Kirmse B, Yu C, et al
    Lower mitochondrial DNA and altered mitochondrial fuel metabolism in hiv-exposed uninfected infants in cameroon.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001647.
    >> Share

    AIDS Res Hum Retroviruses

  15. MERRIAM DP, Chen C, Mendez-Lagares G, Rogers K, et al
    Depletion of gut-resident CCR5+ cells for HIV cure strategies.
    AIDS Res Hum Retroviruses. 2017.
    >> Share

    Antimicrob Agents Chemother

  16. HASSOUNAH SA, Alikhani A, Oliveira M, Bharaj S, et al
    Antiviral Activity of Bictegravir and Cabotegravir Against Integrase Inhibitor Resistant SIVmac239 and HIV-1.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01695.
    >> Share

    Antivir Ther

  17. MARTINEZ-VEGA R, De La Mata NL, Kumarasamy N, Ly PS, et al
    Durability of antiretroviral therapy regimens and determinants for change in HIV-1-infected patients in the TREAT Asia HIV Observational Database (TAHOD-LITE).
    Antivir Ther. 2017 Sep 21. doi: 10.3851/IMP3194.
    >> Share

  18. SHARMA A, Hoover DR, Shi Q, Holman S, et al
    Longitudinal study of falls among HIV-infected and uninfected women: the role of cognition.
    Antivir Ther. 2017 Sep 21. doi: 10.3851/IMP3195.
    >> Share

  19. SRINIVASA S, Lu MT, Fitch KV, Hallett TR, et al
    Epicardial adipose tissue volume and cardiovascular risk indices among asymptomatic women with and without HIV.
    Antivir Ther. 2017 Sep 20. doi: 10.3851/IMP3193.
    >> Share


  20. SADEGHIRAD B, Siemieniuk RAC, Brignardello-Petersen R, Papola D, et al
    Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials.
    BMJ. 2017;358:j3887.
    >> Share

  21. AERTGEERTS B, Agoritsas T, Siemieniuk RAC, Burgers J, et al
    Corticosteroids for sore throat: a clinical practice guideline.
    BMJ. 2017;358:j4090.
    >> Share

    J Acquir Immune Defic Syndr

  22. SHUPER PA, Joharchi N, Monti PM, Loutfy M, et al
    Acute Alcohol Consumption Directly Increases HIV Transmission Risk: A Randomized Controlled Experiment.
    J Acquir Immune Defic Syndr. 2017 Sep 18. doi: 10.1097/QAI.0000000000001549.
    >> Share

  23. GREBE E, Welte A, Hall J, Keating SM, et al
    Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms.
    J Acquir Immune Defic Syndr. 2017 Sep 7. doi: 10.1097/QAI.0000000000001537.
    >> Share

    J Immunol

  24. GHOSH S, Wallerath C, Covarrubias S, Hornung V, et al
    The PYHIN Protein p205 Regulates the Inflammasome by Controlling Asc Expression.
    J Immunol. 2017 Sep 20. pii: ji1700823. doi: 10.4049/jimmunol.1700823.
    >> Share

    J Infect Dis

  25. KOOIJ KW, Vogt L, Wit FWNM, van der Valk M, et al
    Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
    J Infect Dis. 2017;216:622-631.
    >> Share

  26. SMITH B
    Toward Understanding the When and Why of Human Immunodeficiency Virus-Associated Stroke.
    J Infect Dis. 2017;216:509-510.
    >> Share

  27. DE POKOMANDY A, Kaufman E, de Castro C, Mayrand MH, et al
    The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.
    J Infect Dis. 2017;216:447-456.
    >> Share

  28. MOLLAN KR, Tierney C, Hellwege JN, Eron JJ, et al
    Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.
    J Infect Dis. 2017;216:554-564.
    >> Share

  29. ROCKWOOD N, Sirgel F, Streicher E, Warren R, et al
    Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
    J Infect Dis. 2017;216:632-640.
    >> Share

  30. FOLDI J, Kozhaya L, McCarty B, Mwamzuka M, et al
    HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions.
    J Infect Dis. 2017;216:641-650.
    >> Share

  31. PRENDERGAST AJ, Chasekwa B, Rukobo S, Govha M, et al
    Intestinal Damage and Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV)-Exposed and HIV-Infected Zimbabwean Infants.
    J Infect Dis. 2017;216:651-661.
    >> Share

  32. BENJAMIN LA, Allain TJ, Mzinganjira H, Connor MD, et al
    The Role of Human Immunodeficiency Virus-Associated Vasculopathy in the Etiology of Stroke.
    J Infect Dis. 2017;216:545-553.
    >> Share

    J Virol

  33. CONTRERAS-GALINDO RA, Dube D, Fujinaga K, Kaplan MH, et al
    Susceptibility of Human Endogenous Retrovirus Type-K to Reverse Transcriptase Inhibitors.
    J Virol. 2017 Sep 20. pii: JVI.01309-17. doi: 10.1128/JVI.01309.
    >> Share

  34. RIFE MAGALIS B, Nolan DJ, Autissier P, Burdo TH, et al
    Insights into the impact of CD8+ immune modulation on HIV evolutionary dynamics in distinct anatomical compartments using SIV-infected macaque models of AIDS progression.
    J Virol. 2017 Sep 20. pii: JVI.01162-17. doi: 10.1128/JVI.01162.
    >> Share

  35. BROCCA-COFANO E, Kuhrt D, Siewe B, Xu C, et al
    Pathogenic Correlates of the Simian Immunodeficiency Virus (SIV)-Associated B Cell Dysfunction.
    J Virol. 2017 Sep 20. pii: JVI.01051-17. doi: 10.1128/JVI.01051.
    >> Share

  36. VALLE-CASUSO JC, Allouch A, David A, Lenzi GM, et al
    p21 restricts HIV-1 in monocyte-derived dendritic cells through the reduction of dNTP biosynthesis and regulation of SAMHD1 antiviral activity.
    J Virol. 2017 Sep 20. pii: JVI.01324-17. doi: 10.1128/JVI.01324.
    >> Share

  37. GALVIS AE, Fisher HE, Fan H, Camerini D, et al
    Conformational Changes in the 5' End of the HIV-1 Genome Dependent on the Debranching Enzyme DBR1 During Early Stages of Infection.
    J Virol. 2017 Sep 20. pii: JVI.01377-17. doi: 10.1128/JVI.01377.
    >> Share

  38. FAUTEUX-DANIEL S, Larouche A, Calderon V, Boulais J, et al
    Vertical transmission of hepatitis C virus: variable transmission bottleneck and evidence of mid-gestation in utero infection.
    J Virol. 2017 Sep 20. pii: JVI.01372-17. doi: 10.1128/JVI.01372.
    >> Share


  39. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2017;390:1151-1210.
    >> Share

  40. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet. 2017;390:1084-1150.
    >> Share

    Lancet Glob Health

  41. STOCKDALE AJ, Chaponda M, Beloukas A, Phillips RO, et al
    Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis.
    Lancet Glob Health. 2017;5:e992-e1003.
    >> Share

    Lancet HIV

  42. RAFFI F, Allavena C
    Raltegravir becomes a once daily antiretroviral.
    Lancet HIV. 2017 Sep 11. pii: S2352-3018(17)30154.
    >> Share

  43. CAHN P, Kaplan R, Sax PE, Squires K, et al
    Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial.
    Lancet HIV. 2017 Sep 11. pii: S2352-3018(17)30128.
    >> Share

  44. HOORNENBORG E, Prins M, Achterbergh RCA, Woittiez LR, et al
    Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report.
    Lancet HIV. 2017 Sep 14. pii: S2352-3018(17)30132.
    >> Share

    Lancet Infect Dis

  45. BAHR NC, Nuwagira E, Evans EE, Cresswell FV, et al
    Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study.
    Lancet Infect Dis. 2017 Sep 14. pii: S1473-3099(17)30474.
    >> Share

    MMWR Morb Mortal Wkly Rep

  46. TEPPER NK, Krashin JW, Curtis KM, Cox S, et al
    Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.
    MMWR Morb Mortal Wkly Rep. 2017;66:990-994.
    >> Share

  47. SINGH S, Mitsch A, Wu B
    HIV Care Outcomes Among Men Who Have Sex With Men With Diagnosed HIV Infection - United States, 2015.
    MMWR Morb Mortal Wkly Rep. 2017;66:969-974.
    >> Share


  48. CHAUDHURY S, Williams PL, Mayondi GK, Leidner J, et al
    Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.
    Pediatrics. 2017 Sep 14. pii: e20170988. doi: 10.1542/peds.2017-0988.
    >> Share

  49. MILLER H, Slone JS, Raabe E, El-Mallawany NK, et al
    Lessons From Pediatric HIV: A Case for Curative Intent in Pediatric Cancer in LMICs.
    Pediatrics. 2017 Sep 14. pii: e20170525. doi: 10.1542/peds.2017-0525.
    >> Share

    PLoS Comput Biol

  50. LIU Y, Zou X
    Mathematical modeling and quantitative analysis of HIV-1 Gag trafficking and polymerization.
    PLoS Comput Biol. 2017;13:e1005733.
    >> Share

    PLoS One

  51. DECKERT A, Neuhann F, Klose C, Bruckner T, et al
    Assessment of renal function in routine care of people living with HIV on ART in a resource-limited setting in urban Zambia.
    PLoS One. 2017;12:e0184766.
    >> Share

  52. POTEAT T, Park C, Solares D, Williams JK, et al
    Changing hearts and minds: Results from a multi-country gender and sexual diversity training.
    PLoS One. 2017;12:e0184484.
    >> Share

  53. PETRARA MR, Cattelan AM, Sasset L, Freguja R, et al
    Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus.
    PLoS One. 2017;12:e0185128.
    >> Share

  54. MUNIZ CP, Cavalcante LTF, Jia H, Zheng H, et al
    Zoonotic infection of Brazilian primate workers with New World simian foamy virus.
    PLoS One. 2017;12:e0184502.
    >> Share

  55. BORKUM MS, Heckmann JM, Manning K, Dave JA, et al
    High prevalence of "non-dipping" blood pressure and vascular stiffness in HIV-infected South Africans on antiretrovirals.
    PLoS One. 2017;12:e0185003.
    >> Share

  56. TUDESQ JJ, Dunyach-Remy C, Combescure C, Doncesco R, et al
    Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients.
    PLoS One. 2017;12:e0183372.
    >> Share

  57. GOMEZ-MORA E, Massanella M, Garcia E, Giles D, et al
    Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.
    PLoS One. 2017;12:e0184433.
    >> Share

  58. TUMIOTTO C, Riviere L, Bellecave P, Recordon-Pinson P, et al
    Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA.
    PLoS One. 2017;12:e0185211.
    >> Share

  59. MILLER C, Boegler K, Carver S, MacMillan M, et al
    Pathogenesis of oral FIV infection.
    PLoS One. 2017;12:e0185138.
    >> Share

  60. HARRISON RE, Pearson L, Vere M, Chonzi P, et al
    Care requirements for clients who present after rape and clients who presented after consensual sex as a minor at a clinic in Harare, Zimbabwe, from 2011 to 2014.
    PLoS One. 2017;12:e0184634.
    >> Share

  61. CHIU APY, Lin Q, He D
    News trends and web search query of HIV/AIDS in Hong Kong.
    PLoS One. 2017;12:e0185004.
    >> Share

    PLoS Pathog

  62. MARSDEN MD, Loy BA, Wu X, Ramirez CM, et al
    In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication.
    PLoS Pathog. 2017;13:e1006575.
    >> Share

  63. THOMAS AS, Jones KL, Gandhi RT, McMahon DK, et al
    mT-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.
    PLoS Pathog. 2017;13:e1006629.
    >> Share

  64. SEKI S, Nomura T, Nishizawa M, Yamamoto H, et al
    In vivo virulence of MHC-adapted AIDS virus serially-passaged through MHC-mismatched hosts.
    PLoS Pathog. 2017;13:e1006638.
    >> Share

  65. ALLARD A, Althouse BM, Hebert-Dufresne L, Scarpino SV, et al
    The risk of sustained sexual transmission of Zika is underestimated.
    PLoS Pathog. 2017;13:e1006633.
    >> Share

  66. SHRESTHA P, Davis DA, Veeranna RP, Carey RF, et al
    Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma.
    PLoS Pathog. 2017;13:e1006628.
    >> Share


  67. XU L, Pegu A, Rao E, Doria-Rose N, et al
    Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.
    Science. 2017 Sep 20. pii: eaan8630. doi: 10.1126/science.aan8630.
    >> Share


  68. TAN S, Zhang S, Wu B, Zhao Y, et al
    Hemagglutinin-specific CD4+ T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans.
    Vaccine. 2017 Sep 13. pii: S0264-410X(17)31159.
    >> Share


  69. JIA M, Shaw T, Zhang X, Liu D, et al
    Decoding noises in HIV computational genotyping.
    Virology. 2017;511:249-255.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016